New Study Analysis Finds Amgen Cholesterol Drug Lowers Stroke Risk in Certain Patients

New Study Analysis Finds Amgen Cholesterol Drug Lowers Stroke Risk in Certain Patients

Amgen (AMGN) was steady earlier in Tuesday’s late session after the biotech company tonight said a new analysis of its Repatha medication showed lowering low-density lipoprotein cholesterol levels reduced the risk of cardiovascular events in a sub-group of patients with a history of stroke who were participating in a clinical trial of the drug. According to the company, the clinical benefit for potential stroke patients has not been reported before. […]

Read More ˃